OncoCyte Stock (NASDAQ: OCX) stock price, news, charts, stock research, profile.
You can purchase shares of OncoCyte (NASDAQ:OCX) through any online brokerage.
Other companies in OncoCyte’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Kezar Life Sciences (NASDAQ:KZR), Estrella Immunopharma (NASDAQ:ESLA), Gain Therapeutics (NASDAQ:GANX) and CARISMA Therapeutics (NASDAQ:CARM).
OncoCyte has a consensus price target of $3.35.
The stock price for OncoCyte (NASDAQ: OCX) is $2.9775 last updated September 25, 2024 at 11:18 AM EDT.
There are no upcoming dividends for OncoCyte.
OncoCyte’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for OncoCyte.
OncoCyte is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.